Overview
Status
Active
Registry date
2016-01-14
Share capital
50,000.00 PLN
Registered address
ul. Poznańska 50, 62-090 Mrowino, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed.
- 2025not filed
- 202412/07/2025
- 202307/07/2024
- 202212/07/2023
- 202103/07/2022
- 202007/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Bohdan Bashuk – Management Board Member
Iaroslav Turchyn – President of the Management Board
Manner of representation
The persons authorized to make declarations of will on behalf of the company are the President of the Management Board or two of the remaining members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bohdan Bashukage 49 | 250 | $3,376.55 | 25% |
Edward Stefan Lorenzage 69 | 500 | $6,753.11 | 50% |
Iaroslav Turchynage 70 | 250 | $3,376.55 | 25% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| BioencaS.A. | $0.00 | bioenca.pl | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
FAQ
The main business activity of CAS Med Tech focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on January 14, 2016.
The headquarters is located at: ul. Poznańska 50, 62-090 Mrowino.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-04-15